Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial
Launched by VASTRA GOTALAND REGION · Dec 15, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Subjects already included in the OSLT trial (NCT03798223) will be invited to the extended trial (OSLT-R) at the time of SLT re-treatment or when OSLT follow up is scheduled to terminate. Patients are re-treated as needed, according to the randomized group assignment performed in the OSLT inclusion process.
The OSLT-R trial is aiming to elucidate:
* If the SLT efficacy, in terms of relative IOP reduction (percent of baseline IOP), changes with additional SLT iterations.
* If the longevity of IOP reduction after SLT changes with additional SLT iterations.
* If repeated SLT is associated wit...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Included in the OSLT trial
- • Followed up without the need for other treatment escalation than repeat SLT
- Exclusion Criteria:
- • Unable to participate in follow up due to health conditions, strength or physical location.
About Vastra Gotaland Region
Vastra Gotaland Region is a prominent healthcare organization in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, the region leverages its extensive network of hospitals and healthcare professionals to facilitate high-quality research initiatives that address pressing health challenges. With a commitment to ethical standards and patient safety, Vastra Gotaland Region strives to foster collaboration between researchers, clinicians, and patients, ensuring that clinical trials contribute valuable insights and advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Skövde, Vastra Gotaland, Sweden
Uddevalla, Vastra Gotaland, Sweden
Patients applied
Trial Officials
Tobias Dahlgren, MD
Principal Investigator
Vastra Gotaland Region
Marcelo Ayala, MD, PhD
Study Chair
Vastra Gotaland Region
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials